Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAgronomics Regulatory News (ANIC)

Share Price Information for Agronomics (ANIC)

Share Price is delayed by 15 minutes
Get Live Data
5.20    0.05 (0.98%)
Bid:
5.10
Ask:
5.30
Spread: 0.20 (3.922%)
Market Cap: £55.79m
ANIC Live PriceLast checked at - London Stock Exchange

Intraday Agronomics Share Chart

Proposed Fundraise

11 Nov 2019 07:00

RNS Number : 8863S
Agronomics Limited
11 November 2019
 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY MEMBER STATE OF THE EEA (OTHER THAN THE UNITED KINGDOM) OR ANY OTHER JURISDICTION IN WHICH THE PUBLICATION, DISTRIBUTION OR RELEASE OF THIS ANNOUNCEMENT WOULD BE UNLAWFUL. PLEASE SEE THE SECTION ENTITLED "IMPORTANT NOTE" TOWARDS THE END OF THIS ANNOUNCEMENT.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 ('MAR). Upon the publication of this announcement via a Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain.

 

11 November 2019

Agronomics Ltd

("Agronomics" or the "Company")

Response to Press Speculation regarding a Proposed Fundraise of up to £20 million

Appointment of Zeus Capital as Joint Broker

In response to press speculation over the weekend, the Company confirms that it is putting in place plans to raise up to £20 million through an issue of new Ordinary Shares, further details of which are set out below.

Background to the Proposed Fundraise

On 29 October 2019, Agronomics announced that it had made an investment in Shiok Meats, on 17 October 2019, Agronomics announced that it had made a further investment in Vitrolabs Inc, and on 15 October 2019, it announced an investment into Rebellyous Foods. Given the scale of the opportunity to invest in the nascent "cultivated meat" and related sectors, and the resources available after the completion of recent investments, the Company's board has approved in principle a proposed equity raise to finance its growing pipeline of opportunities. The Company proposes to target a raise of up to £20 million through an issue of new Ordinary Shares (the "Fundraise").

The Company's intention is to price the new shares offered pursuant to the Fundraise at the unaudited net asset value per share of the Company's portfolio at 30 September 2019, being 5.5p. The Board reserves the right to increase or decrease the size of the Fundraise or alter the proposed price at which new shares are offered, depending on demand and the strategic value to the Company of proposed investors. The Fundraise is expected to close by 29 November 2019 at which time a further announcement will be made.

The Company has appointed Zeus Capital Limited ("Zeus Capital") to act as its broker to assist with the Fundraise.

Appointment of Joint- Broker

Prior to launching the roadshow for the proposed placing, the Company is pleased to announce the appointment of Zeus Capital Limited as the Company's co-broker with immediate effect.

The Placing

The Placing will take place through the Company's Joint Brokers, Zeus Capital and Peterhouse Corporate Finance. This Placing will take place after a roadshow being arranged by Zeus Capital. The final number and pricing of new Ordinary Shares will be agreed between the Company and Zeus Capital following close of the Placing and announced shortly thereafter. Details of the Placing will be announced upon completion of the roadshow. Parties interested in participating in the Fundraise should contact Zeus Capital at the contact details below.

Nothing in this announcement comprises an offer to any person to subscribe for any Ordinary Shares.

Directors' Participation

Jim Mellon, a Non-Executive Director, has indicated to the Board his willingness to participate in the Proposed Fundraise in an amount of up to £2 million (subject to his shareholding and that of any parties of which he is deemed as being in concert remaining below 30%). It is expected that Richard Reed, Non-Executive Chairman will also participate in the Fundraise. To the extent that such participations are Related Party Transactions under the AIM Rules for Companies, the requirements of the AIM Rules will be dealt with at the time that the terms of the fundraise are announced.

Termination of Optiva as Broker

Concurrent with the appointment of Zeus as Joint Broker (effective today) the appointment of Optiva Securities Limited as broker to the Company has been terminated.

 

For further information, please contact:

 

Agronomics Limited

Beaumont Cornish Limited

 

Zeus Capital

Peterhouse Corporate Finance

The Company

 

Nomad

Joint Broker

Joint Broker

Richard Reed

Denham Eke

 

Roland Cornish

James Biddle

 

Mike Seabrook

Rupert Woolfenden

 

Lucy Williams

 

+44 (0) 1624 639396

+44 (0) 207 628 3396

+44 (0) 20 3829 5000

+44 (0) 207 469 0936

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCGMMMMZGMGLZZ
Date   Source Headline
10th Jul 202611:03 amRNSNet Asset Value as at 30 June 2026
25th Jun 20267:00 amRNS-RPortfolio company Tropic acquires Rahan Meristem
4th Jun 20265:59 pmRNS-RAgronomics portfolio company HydGene Update
4th Jun 20265:58 pmRNS-RAgronomics portfolio company Bond Pet Foods Update
18th May 20267:00 amRNSNet Asset Value calculation as at 31 March 2026
12th May 20267:00 amRNSAgronomics leads US$5m investment in SuperMeat
7th May 20264:04 pmRNSMeatly completes £10.4 million Series A funding
15th Apr 20261:29 pmRNS-RClean Food Group Update
14th Apr 20267:00 amRNS-RTropic’s product receives regulatory approval
1st Apr 202612:50 pmRNS-RAll G secures FDA "no questions" letter
25th Mar 20263:45 pmRNS-RClean Food Group Update
19th Mar 202612:30 pmRNS-RTropic Biosciences Update
12th Mar 20265:31 pmRNSDirector's Dealing
4th Mar 20267:00 amRNSDirector’s Dealing
25th Feb 20265:04 pmRNSDirector’s Dealing
20th Feb 20265:15 pmRNSDirector’s Dealing
19th Feb 20262:10 pmRNSDirector’s Dealing
17th Feb 20267:00 amRNSHalf-year Financial Report
13th Feb 20264:31 pmRNSResult of AGM
9th Feb 20267:00 amRNSNet Asset Value calculation as at 31 December 2025
15th Jan 20267:00 amRNSAgronomics invests A$3m in All G & Issue of Equity
30th Dec 20258:00 amRNSFinal Results and Notice of AGM
30th Dec 20258:00 amRNSFinal Results and Notice of AGM
30th Dec 20257:00 amRNSFurther equity investment in BlueNalu
30th Dec 20257:00 amRNSFurther equity investment in BlueNalu
19th Dec 20259:30 amRNSLiberation Bioindustries Series A1 equity round
19th Dec 20259:30 amRNSDissolution of Meatable
19th Dec 20259:30 amRNSDissolution of Meatable
19th Dec 20259:30 amRNSLiberation Bioindustries Series A1 equity round
21st Nov 20258:00 amRNSAgronomics invests US$ 2 million in SuperMeat
13th Nov 20257:00 amRNSNet Asset Value as at 30 September 2025
10th Nov 20257:00 amRNS-REVERY raise US$ 55 million in fresh capital
21st Oct 20257:00 amRNS-RGeltor, Inc Update
30th Sep 20257:00 amRNS-RClean Food Group Update
23rd Sep 20257:00 amRNS-ROnego Bio Update
12th Sep 20258:00 amRNS-RClean Food Group Update
22nd Aug 20258:19 amRNS-RMeatable acquires Meat Technology platform
24th Jul 20257:00 amRNS-RSolar Foods Update
18th Jul 202511:00 amRNSNet Asset Value calculation as at 30 June 2025
11th Jun 20257:00 amRNS-RAgronomics Q2 2025 Newsletter
28th May 20252:55 pmRNS-RMeatly reduces bioreactor and medium costs
12th May 20257:00 amRNSNet Asset Value calculation as at 31 March 2025
8th May 20257:00 amRNS-RLiberation Labs Announce Manufacturing Partnership
6th May 20257:00 amRNS-RMeatable and TruMeat Forge Alliance
30th Apr 20257:00 amRNS-RBlueNalu Expands Partnership with Nomad Foods
15th Apr 20259:00 amRNS-RLiberation Labs secures strategic partnership
18th Mar 20257:00 amRNSExercise of Shellbay options
14th Mar 20258:15 amRNSUnaudited Interim Results
4th Mar 20258:00 amRNS-RSolar Foods Secures €10 million Grant
7th Feb 20253:33 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.